{"entity":{"type":"insider","cik":"0001827317","url":"/insider/0001827317","json_url":"/insider/0001827317.json","name":"Nicholson Nur","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":12,"first":"2023-09-19","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Nicholson Nur","source":"filing","n_filings":12,"first_seen":"2023-09-19","last_seen":"2026-01-23"}],"transactions":[{"id":5894999,"accession":"0001492422-26-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000056","line_url":"/filing/0001492422-26-000056#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7725.0,"shares_display":"7,725","price_per_share":21.7654,"price_display":"21.77","price_state":"stated","total_value":168137.715,"total_display":"168,137.72","total_whole":"168,138","shares_owned_after":71118.0,"shares_owned_after_display":"71,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":5881418,"accession":"0001492422-26-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000040","line_url":"/filing/0001492422-26-000040#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2203.0,"shares_display":"2,203","price_per_share":19.7929,"price_display":"19.79","price_state":"stated","total_value":43603.7587,"total_display":"43,603.76","total_whole":"43,604","shares_owned_after":78843.0,"shares_owned_after_display":"78,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":6185556,"accession":"0001492422-26-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000027","line_url":"/filing/0001492422-26-000027#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2618.0,"shares_display":"2,618","price_per_share":22.1872,"price_display":"22.19","price_state":"stated","total_value":58086.0896,"total_display":"58,086.09","total_whole":"58,086","shares_owned_after":81046.0,"shares_owned_after_display":"81,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":5084791,"accession":"0001127602-25-002383","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-002383","line_url":"/filing/0001127602-25-002383#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":825.0,"shares_display":"825","price_per_share":29.5236,"price_display":"29.52","price_state":"stated","total_value":24356.97,"total_display":"24,356.97","total_whole":"24,357","shares_owned_after":83664.0,"shares_owned_after_display":"83,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":4765399,"accession":"0001127602-25-001841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001841","line_url":"/filing/0001127602-25-001841#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3948.0,"shares_display":"3,948","price_per_share":30.4255,"price_display":"30.43","price_state":"stated","total_value":120119.874,"total_display":"120,119.87","total_whole":"120,120","shares_owned_after":84489.0,"shares_owned_after_display":"84,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4765361,"accession":"0001127602-25-001625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001625","line_url":"/filing/0001127602-25-001625#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2145.0,"shares_display":"2,145","price_per_share":29.9582,"price_display":"29.96","price_state":"stated","total_value":64260.339,"total_display":"64,260.34","total_whole":"64,260","shares_owned_after":52011.0,"shares_owned_after_display":"52,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":5163834,"accession":"0001127602-25-001201","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001201","line_url":"/filing/0001127602-25-001201#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2632.0,"shares_display":"2,632","price_per_share":28.7021,"price_display":"28.70","price_state":"stated","total_value":75543.9272,"total_display":"75,543.93","total_whole":"75,544","shares_owned_after":54156.0,"shares_owned_after_display":"54,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-14","scope":"insider"},{"id":2420622,"accession":"0001127602-24-010127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-010127","line_url":"/filing/0001127602-24-010127","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11220.0,"shares_display":"11,220","price_per_share":57.56128502673797,"price_display":"57.56","price_state":"stated","total_value":645837.618,"total_display":"645,837.62","total_whole":"645,838","shares_owned_after":59739.0,"shares_owned_after_display":"59,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-14","scope":"insider","n_lines":2},{"id":3023771,"accession":"0001127602-24-002746","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-002746","line_url":"/filing/0001127602-24-002746#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":835.0,"shares_display":"835","price_per_share":64.1382,"price_display":"64.14","price_state":"stated","total_value":53555.397,"total_display":"53,555.40","total_whole":"53,555","shares_owned_after":67507.0,"shares_owned_after_display":"67,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":3240193,"accession":"0001127602-24-001953","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-001953","line_url":"/filing/0001127602-24-001953#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2593.0,"shares_display":"2,593","price_per_share":64.996,"price_display":"65.00","price_state":"stated","total_value":168534.628,"total_display":"168,534.63","total_whole":"168,535","shares_owned_after":68342.0,"shares_owned_after_display":"68,342","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":2419563,"accession":"0001127602-24-001437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-001437","line_url":"/filing/0001127602-24-001437#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1857.0,"shares_display":"1,857","price_per_share":66.8086,"price_display":"66.81","price_state":"stated","total_value":124063.5702,"total_display":"124,063.57","total_whole":"124,064","shares_owned_after":70935.0,"shares_owned_after_display":"70,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":8360415,"accession":"0001127602-23-024445","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-024445","line_url":"/filing/0001127602-23-024445","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001827317","owner_name":"Nicholson Nur","owner_display_name":"Nicholson Nur","owner_url":"/insider/0001827317","role":"Officer (Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20350.0,"shares_display":"20,350","price_per_share":44.266003366093365,"price_display":"44.27","price_state":"stated","total_value":900813.1685,"total_display":"900,813.17","total_whole":"900,813","shares_owned_after":53284.0,"shares_owned_after_display":"53,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Officer (Chief Technical Officer)","n_filings":12,"first_seen":"2023-09-19","last_seen":"2026-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001827317","retrieved_at":"2026-08-27T07:23:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}